Many people with myeloma have tried CAR-T cell therapy, especially when other treatments stopped working. The experience varies, but it has shown promising results for many.
In clinical trials, about 3 out of 4 people saw their cancer signs reduce, and 1 out of 3 had a complete response where all signs of cancer Show Full Answer
Many people with myeloma have tried CAR-T cell therapy, especially when other treatments stopped working. The experience varies, but it has shown promising results for many.
In clinical trials, about 3 out of 4 people saw their cancer signs reduce, and 1 out of 3 had a complete response where all signs of cancer disappeared. Among those with complete responses, 2 out of 3 remained in remission for at least a year.
However, it's important to know that nearly everyone who receives this treatment experiences some side effects. The most common include:
- Flu-like symptoms (fever, chills, tiredness)
- Cytokine release syndrome (CRS) - affecting about 84% of people
- Muscle aches and headaches
- Infections and weakened immune system
- Nervous system issues in some cases
Most side effects are manageable with treatment, though some can be serious. That's why CAR-T therapy is only available at specially certified centers where medical teams are trained to handle complications.
The therapy isn't a cure, and cancer can return. But for people with hard-to-treat myeloma who've already tried multiple treatments, it's offered hope when other options haven't worked. You'll need close monitoring during and after treatment, often staying near the treatment center for a month or more.
November 30, 2025